A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Chad J. Creighton, Xiaoxian Li, Melissa D. Landis et al. · Proceedings of the National Academy of Sciences · 2009 · 1.4K citations · Full text

Medicine, Cancer Biology, Oncology +16

Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy

Michael F. Marmor, Ulrich Kellner, Timothy Y. Y. Lai et al. · Ophthalmology · 2011 · 715 citations

Medicine, Ophthalmology, Preventive Medicine +11

Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer

Stephen E. Jones, John K. Erban, Beth Overmoyer et al. · Journal of Clinical Oncology · 2005 · 547 citations · Full text

Medicine, Oncology, Pharmacology +14

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Jean‐Marc Nabholtz, H.-J. Senn, W.R. Bezwoda et al. · Journal of Clinical Oncology · 1999 · 506 citations

Medicine, Oncology, Pharmacology +12

BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.

Francis Y. F. Lee, R. M. Borzilleri, Craig R. Fairchild et al. · PubMed · 2001 · 455 citations

Medicine, Oncology, Pharmacology +13